HLB Co., Ltd.
028300
Classifica tra le azioni
#4152
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Prezzo delle azioni
$29.32
Capitalizzazione di mercato
$3.90B
Variazione (1 giorno)
-1.28%
Variazione (1 anno)
-8.35%
Paese
KR
Scambia HLB Co., Ltd. (028300)
Categoria
Healthcare
Rapporto P/B per HLB Co., Ltd. (028300)
Rapporto P/B al October 2026 TTM: 15.65
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di HLB Co., Ltd., il rapporto P/B attuale (TTM) è 15.65. Alla fine del 2023, era pari a 12.31.
Storico del rapporto P/B per HLB Co., Ltd. da 2012 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 15.65 | -5.53% |
| 2024 | 16.57 | 34.60% |
| 2023 | 12.31 | 162.53% |
| 2022 | 4.69 | -46.47% |
| 2021 | 8.76 | -19.54% |
| 2020 | 10.89 | -58.32% |
| 2019 | 26.12 | 50.87% |
| 2018 | 17.32 | -17.44% |
| 2017 | 20.97 | 262.79% |
| 2016 | 5.78 | -35.05% |
| 2015 | 8.90 | 6.84% |
| 2014 | 8.33 | 133.99% |
| 2013 | 3.56 | 31.96% |
| 2012 | 2.70 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 6.251 | -60.07% |
US
|
|
| 13.2547 | -15.33% |
US
|
|
| 4.208 | -73.12% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | -60.51% |
NL
|
